Optimized supply chain and governance for an Aesthetic Medicine company, resulting in a 15% boost in manufacturing efficiency, 20% reduction in compliance incidents, and enhanced profitability, enabling revenue growth and asset acquisition.
Approach
- Multi-phased engagement designed to provide dual-sided guidance to improve critical supplier relations, longer term strategic decision making and operational results
- Phase 1: Comprehensive assessment and gap-analysis targeting operational improvements in quality, productivity, service and talent
- Phase 2: Serve as interim general management to orientate and execute near to mid-term change management
Results
- 15% Organizational priorities were realigned, which remediated and enhanced manufacturing performance, quality, and supply chain scalability. This resulted in a 15% increase in manufacturing efficiency.
- 20% GMP compliance was improved through enforced Quality System procedural integrity and organizational accountability, leading to a 20% reduction in compliance-related incidents.
- Improved client interface thru multi-level talent investments in Manufacturing, Quality, Engineering, Planning and Finance
- Improved P&L margins because of broader profitability analysis and productivity improvements
- Reverted value proposition to increase revenue growth
- Provided a platform for acquisition and transfer of Manufacturing Assets and Site Operations to primary client
Segment: MedTech · Services: supply-chain-planning, supply-chain-integration